Valuation
Valuation - $896047 analysis on 6ix (Biocryst Pharmaceuticals, Inc.)
Track Biocryst Pharmaceuticals, Inc. (896047) on 6ix - releases, events, and the audience already following the stock.
Biocryst Pharmaceuticals, Inc.
Valuation for $896047 (Biocryst Pharmaceuticals, Inc.) on 6ix - drill into the data behind a Simply Wall St-style analysis.